• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用脂质体作为多酚化合物的载体:以反式白藜芦醇为例。

Using liposomes as carriers for polyphenolic compounds: the case of trans-resveratrol.

机构信息

Pharmaceutical and Applied Chemistry Departments & CSGI, University of Siena, Siena, Italy.

出版信息

PLoS One. 2012;7(8):e41438. doi: 10.1371/journal.pone.0041438. Epub 2012 Aug 22.

DOI:10.1371/journal.pone.0041438
PMID:22936976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3425584/
Abstract

Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a polyphenol found in various plants, especially in the skin of red grapes. The effect of resveratrol on human health is the topic of numerous studies. In fact this molecule has shown anti-cancer, anti-inflammatory, blood-sugar-lowering ability and beneficial cardiovascular effects. However, for many polyphenol compounds of natural origin bioavailability is limited by low solubility in biological fluids, as well as by rapid metabolization in vivo. Therefore, appropriate carriers are required to obtain efficient therapeutics along with low administration doses.Liposomes are excellent candidates for drug delivery purposes, due to their biocompatibility, wide choice of physico-chemical properties and easy preparation.In this paper liposome formulations made by a saturated phosphatidyl-choline (DPPC) and cholesterol (or its positively charged derivative DC-CHOL) were chosen to optimize the loading of a rigid hydrophobic molecule such as resveratrol.Plain and resveratrol loaded liposomes were characterized for size, surface charge and structural details by complementary techniques, i.e. Dynamic Light Scattering (DLS), Zeta potential and Small Angle X-ray Scattering (SAXS). Nuclear and Electron Spin magnetic resonances (NMR and ESR, respectively) were also used to gain information at the molecular scale.The obtained results allowed to give an account of loaded liposomes in which resveratrol interacted with the bilayer, being more deeply inserted in cationic liposomes than in zwitterionic liposomes. Relevant properties such as the mean size and the presence of oligolamellar structures were influenced by the loading of RESV guest molecules.The toxicity of all these systems was tested on stabilized cell lines (mouse fibroblast NIH-3T3 and human astrocytes U373-MG), showing that cell viability was not affected by the administration of liposomial resveratrol.

摘要

白藜芦醇(3,5,4'-三羟基反式-二苯乙烯)是一种存在于各种植物中的多酚,特别是在红葡萄皮中。白藜芦醇对人类健康的影响是众多研究的主题。事实上,这种分子具有抗癌、抗炎、降血糖和有益心血管的作用。然而,对于许多天然来源的多酚化合物,其生物利用度受到生物流体中低溶解度以及体内快速代谢的限制。因此,需要适当的载体来获得高效的治疗方法,同时降低给药剂量。

脂质体由于其生物相容性、广泛的物理化学性质选择和易于制备,是药物输送的理想选择。在本文中,选择了由饱和磷脂酰胆碱(DPPC)和胆固醇(或其带正电荷的衍生物 DC-CHOL)制成的脂质体配方,以优化刚性疏水分子如白藜芦醇的负载。通过互补技术,即动态光散射(DLS)、Zeta 电位和小角 X 射线散射(SAXS),对空白和负载白藜芦醇的脂质体进行了大小、表面电荷和结构细节的表征。还使用核和电子自旋磁共振(NMR 和 ESR,分别)在分子尺度上获取信息。

所得结果说明,白藜芦醇与双层相互作用的负载脂质体中,白藜芦醇在阳离子脂质体中比在两性离子脂质体中更深地插入。相关性质,如平均大小和寡层结构的存在,受到负载 RESV 客体分子的影响。

所有这些系统的毒性都在稳定的细胞系(小鼠成纤维细胞 NIH-3T3 和人星形胶质细胞 U373-MG)上进行了测试,结果表明,脂质体白藜芦醇的给药不会影响细胞活力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/06879404b3b1/pone.0041438.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/4cb13eba68f9/pone.0041438.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/e0d415cc4265/pone.0041438.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/48f558cddd8b/pone.0041438.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/d65fc4f99714/pone.0041438.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/9bd52b12780f/pone.0041438.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/16481d862d81/pone.0041438.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/ae5195403280/pone.0041438.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/2595f8d1d6fa/pone.0041438.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/c87175a92dbd/pone.0041438.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/1d8f298c5627/pone.0041438.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/bcd891588491/pone.0041438.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/06879404b3b1/pone.0041438.g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/4cb13eba68f9/pone.0041438.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/e0d415cc4265/pone.0041438.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/48f558cddd8b/pone.0041438.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/d65fc4f99714/pone.0041438.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/9bd52b12780f/pone.0041438.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/16481d862d81/pone.0041438.g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/ae5195403280/pone.0041438.g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/2595f8d1d6fa/pone.0041438.g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/c87175a92dbd/pone.0041438.g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/1d8f298c5627/pone.0041438.g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/bcd891588491/pone.0041438.g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b2e/3425584/06879404b3b1/pone.0041438.g012.jpg

相似文献

1
Using liposomes as carriers for polyphenolic compounds: the case of trans-resveratrol.使用脂质体作为多酚化合物的载体:以反式白藜芦醇为例。
PLoS One. 2012;7(8):e41438. doi: 10.1371/journal.pone.0041438. Epub 2012 Aug 22.
2
Physico-chemical characterization of succinyl chitosan-stabilized liposomes for the oral co-delivery of quercetin and resveratrol.壳聚糖琥珀酸酯稳定脂质体的理化性质及其对槲皮素和白藜芦醇口服共递送的研究。
Carbohydr Polym. 2017 Feb 10;157:1853-1861. doi: 10.1016/j.carbpol.2016.11.072. Epub 2016 Nov 25.
3
Comparative study of transdermal drug delivery systems of resveratrol: High efficiency of deformable liposomes.白藜芦醇经皮给药系统的比较研究:变形脂质体的高效性。
Mater Sci Eng C Mater Biol Appl. 2018 Sep 1;90:356-364. doi: 10.1016/j.msec.2018.04.073. Epub 2018 Apr 28.
4
Resveratrol and other Stilbenes: Effects on Dysregulated Gene Expression in Cancers and Novel Delivery Systems.白藜芦醇和其他芪类化合物:对癌症中失调基因表达的影响及新型传递系统。
Anticancer Agents Med Chem. 2021;21(5):567-574. doi: 10.2174/1871520620666200705220722.
5
Nano- and micro-encapsulated systems for enhancing the delivery of resveratrol.用于增强白藜芦醇递送的纳米和微囊化系统。
Ann N Y Acad Sci. 2013 Jul;1290:107-12. doi: 10.1111/nyas.12130.
6
Resveratrol-loaded liposomes for topical treatment of the vaginal inflammation and infections.负载白藜芦醇的脂质体用于阴道炎症和感染的局部治疗。
Eur J Pharm Sci. 2015 Nov 15;79:112-21. doi: 10.1016/j.ejps.2015.09.007. Epub 2015 Sep 7.
7
Resveratrol loaded in cationic glucosylated liposomes to treat Staphylococcus epidermidis infections.负载于阳离子糖基化脂质体中的白藜芦醇用于治疗表皮葡萄球菌感染。
Chem Phys Lipids. 2022 Mar;243:105174. doi: 10.1016/j.chemphyslip.2022.105174. Epub 2022 Jan 14.
8
Stability, biocompatibility and antioxidant activity of PEG-modified liposomes containing resveratrol.含白藜芦醇的聚乙二醇修饰脂质体的稳定性、生物相容性和抗氧化活性。
Int J Pharm. 2018 Mar 1;538(1-2):40-47. doi: 10.1016/j.ijpharm.2017.12.047. Epub 2017 Dec 30.
9
Polyphenol nanoformulations for cancer therapy: experimental evidence and clinical perspective.用于癌症治疗的多酚纳米制剂:实验证据与临床前景
Int J Nanomedicine. 2017 Apr 4;12:2689-2702. doi: 10.2147/IJN.S131973. eCollection 2017.
10
Development and evaluation of emulsion-liposome blends for resveratrol delivery.用于白藜芦醇递送的乳液-脂质体混合物的开发与评价
J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):2950-8. doi: 10.1166/jnn.2006.420.

引用本文的文献

1
Development and Evaluation of Trans-Resveratrol-Loaded Transfersomes: Role of Cholesterol in Formulation Design for Dermal Delivery.载有反式白藜芦醇的传递体的开发与评价:胆固醇在皮肤给药制剂设计中的作用。
Nanotechnol Sci Appl. 2025 Jul 31;18:359-375. doi: 10.2147/NSA.S529010. eCollection 2025.
2
Novel Azole-Modified Porphyrins for Mitochondria-Targeted Photodynamic Therapy.用于线粒体靶向光动力疗法的新型唑修饰卟啉
Molecules. 2025 Jun 21;30(13):2688. doi: 10.3390/molecules30132688.
3
Nano-Based Drug Delivery Systems for Managing Diabetes: Recent Advances and Future Prospects.

本文引用的文献

1
Metabolic patterns and biotransformation activities of resveratrol in human glioblastoma cells: relevance with therapeutic efficacies.白藜芦醇在人神经胶质瘤细胞中的代谢模式和生物转化活性:与治疗效果的相关性。
PLoS One. 2011;6(11):e27484. doi: 10.1371/journal.pone.0027484. Epub 2011 Nov 11.
2
New perspectives in cell communication: Bioelectromagnetic interactions.细胞通讯的新视角:生物电磁相互作用。
Semin Cancer Biol. 2011 Jun;21(3):207-14. doi: 10.1016/j.semcancer.2011.04.003. Epub 2011 May 6.
3
Trans- but not cis-resveratrol impairs angiotensin-II-mediated vascular inflammation through inhibition of NF-κB activation and peroxisome proliferator-activated receptor-gamma upregulation.
用于糖尿病管理的纳米药物递送系统:最新进展与未来展望
Int J Nanomedicine. 2025 May 16;20:6221-6252. doi: 10.2147/IJN.S508875. eCollection 2025.
4
Effect of cucurbit[7]uril on DPPC-containing liposomes: Interactions with the lipid bilayer.葫芦[7]脲对含二棕榈酰磷脂酰胆碱脂质体的影响:与脂质双层的相互作用。
Sci Prog. 2025 Apr-Jun;108(2):368504251334687. doi: 10.1177/00368504251334687. Epub 2025 Apr 17.
5
The Role of Glycolipids and their Toxicity in the Context of Nanomaterials and Nanoparticles: A Review of the Literature.糖脂及其在纳米材料和纳米颗粒背景下的毒性作用:文献综述
Curr Drug Targets. 2025;26(8):571-585. doi: 10.2174/0113894501347158250305074908.
6
Nose to brain strategy coupled to nano vesicular system for natural products delivery: Focus on synaptic plasticity in Alzheimer's disease.用于天然产物递送的鼻脑给药策略与纳米囊泡系统相结合:聚焦阿尔茨海默病中的突触可塑性
J Pharm Anal. 2024 Dec;14(12):101057. doi: 10.1016/j.jpha.2024.101057. Epub 2024 Aug 5.
7
Cardioprotective effects of liposomal resveratrol in diabetic rats: unveiling antioxidant and anti-inflammatory benefits.脂溶性白藜芦醇对糖尿病大鼠的心脏保护作用:揭示抗氧化和抗炎益处。
Redox Rep. 2024 Dec;29(1):2416835. doi: 10.1080/13510002.2024.2416835. Epub 2024 Nov 4.
8
Unveiling New Horizons: Advancing Technologies in Cosmeceuticals for Anti-Aging Solutions.揭示新视野:推进化妆品科技,实现抗衰老解决方案。
Molecules. 2024 Oct 15;29(20):4890. doi: 10.3390/molecules29204890.
9
Derivatization of Hyaluronan to Target Neuroblastoma and Neuroglioma Expressing CD44.透明质酸衍生化以靶向表达CD44的神经母细胞瘤和神经胶质瘤。
Pharmaceutics. 2024 Jun 20;16(6):836. doi: 10.3390/pharmaceutics16060836.
10
Therapeutic Applications of Nanoformulated Resveratrol and Quercetin Phytochemicals in Colorectal Cancer-An Updated Review.纳米制剂白藜芦醇和槲皮素植物化学物质在结直肠癌中的治疗应用——最新综述
Pharmaceutics. 2024 Jun 4;16(6):761. doi: 10.3390/pharmaceutics16060761.
反式而非顺式白藜芦醇通过抑制 NF-κB 激活和过氧化物酶体增殖物激活受体-γ的上调来损害血管紧张素-II 介导的血管炎症。
J Immunol. 2010 Sep 15;185(6):3718-27. doi: 10.4049/jimmunol.1001043. Epub 2010 Aug 13.
4
Identification of metabolic pattern and bioactive form of resveratrol in human medulloblastoma cells.鉴定白藜芦醇在人类成神经管细胞瘤细胞中的代谢模式和生物活性形式。
Biochem Pharmacol. 2010 May 15;79(10):1516-25. doi: 10.1016/j.bcp.2010.01.022. Epub 2010 Jan 25.
5
Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.姜黄素和白藜芦醇联合的脂质体包封降低PTEN基因敲除小鼠的前列腺癌发病率。
Int J Cancer. 2009 Jul 1;125(1):1-8. doi: 10.1002/ijc.24336.
6
Spin-labeled stearic acid behavior and perturbations on the structure of a gel-phase-lipid bilayer in water: 5-, 12- and 16-SASL.
J Phys Chem B. 2008 Dec 25;112(51):16830-42. doi: 10.1021/jp806476a.
7
Effect of resveratrol incorporated in liposomes on proliferation and UV-B protection of cells.脂质体包裹的白藜芦醇对细胞增殖及紫外线B防护的作用
Int J Pharm. 2008 Nov 3;363(1-2):183-91. doi: 10.1016/j.ijpharm.2008.07.024. Epub 2008 Jul 31.
8
Stacking interaction study of trans-resveratrol (trans-3,5,4'-trihydroxystilbene) in solution by Nuclear Magnetic Resonance and Fourier Transform Infrared Spectroscopy.通过核磁共振和傅里叶变换红外光谱法对反式白藜芦醇(反式-3,5,4'-三羟基二苯乙烯)在溶液中的堆积相互作用研究。
Magn Reson Chem. 2008 Jul;46(7):625-9. doi: 10.1002/mrc.2217.
9
Therapeutic potential of resveratrol: the in vivo evidence.白藜芦醇的治疗潜力:体内证据
Nat Rev Drug Discov. 2006 Jun;5(6):493-506. doi: 10.1038/nrd2060. Epub 2006 May 26.
10
Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.采用析因设计法开发负载维生素的局部脂质体制剂:药物沉积与稳定性
Int J Pharm. 2006 Aug 31;320(1-2):37-44. doi: 10.1016/j.ijpharm.2006.04.001. Epub 2006 Apr 7.